VIRAX BIOLABS GROUP LTD's ticker is and the CUSIP is G9495L109. A total of 6 filers reported holding VIRAX BIOLABS GROUP LTD in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $35 | – | 48,458 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| UBS Group AG | 147 | $48 | 0.00% |
| WELLS FARGO & COMPANY/MN | 2,000 | $650 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| Citadel Advisors | 16,362 | $5,318 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 15,000 | $4,875 | 0.00% |